In the news:
- Dart Therapeutics completes study of Convergence’s EIM device as a new biomarker for Duchenne Muscular Dystrophy (DMD).
- Prize4Life’s $1M ALS Biomarker Prize Awarded to Dr. Seward Rutkove for his development of a technology that will accelerate the discovery of treatments for ALS/Lou Gehrig’s disease.
Dr. Seward Rutkove Identifies New Biomarker for ALS; Delivery Could Propel Development of New Treatments for Fatal Neuromuscular Disease
- Charley’s Fund Newsletter